-
Packaging Management of Drug Products for Clinical Use
Features
Muhammad Asim NiaziMarch 21, 2023
Pharma products for clinical purposes also require specialized packaging procedures compared to commercial products.
-
20 Best-selling Drugs in the World by 2025
Features
Lin ZhangAugust 25, 2021
2020, the year of the COVID-19 pandemic, presented significant challenges to every market in the world. However, the pharmaceutical market has still been able to adapt to this new situation and continues to grow quickly.
-
Introduction of FDA Regulatory Education for Industry (REdI) Annual Conference 2021
Features
Lin ZhangAugust 16, 2021
There are many educational events in FDA throughout the year that focus on the pharmaceutical and regulatory industries.
-
FDA Orange Book 101
Features
Lin ZhangFebruary 04, 2021
There are thousands of drugs out there, each with specific benefits, potential side effects, and possible interactions, with many of the drugs being equivalent to one another or serving as alternative treatments for the same issue.
-
Pharma and Health from Ingredients to Pills: What’s NEW on FDA Easy Labeling ?
Features
Lin ZhangNovember 23, 2020
Medicine labeling is important and affects individual health on a daily basis, for patients, and the effectiveness of prescriptions for healthcare professionals.
-
The Impact of the U.S.Presidential Election on the Pharmaceutical Industry
Features
Lin ZhangOctober 22, 2020
As November approaches, the topic of the upcoming United States Presidential Election is becoming more and more significant.
-
NASH: Seizing Opportunities in the Untapped Market
Features
Neeta RatanghayraApril 23, 2020
Nonalcholic steatohepatitis (NASH) is a hard to diagnose liver disease, characterized by steatosis, chronic inflammation, and progressive fibrosis that may lead to cirrhosis, liver failure. NASH is also a significant risk factor for the development of hep
-
IIVS and Toxys Enter into Agreement to Offer ToxTracker® for In Vitro Genetic Toxicity Evaluation
Market news
PharmaSourcesMarch 10, 2023
The Institute for In Vitro Sciences (IIVS) and Toxys have entered into a license agreement that allows IIVS to offer the ToxTracker assay.
-
US healthcare groups publish drug supply chain recommendations
Market news
EuropeanPharmaceuticalReviewDecember 23, 2021
American healthcare groups have released a series of policy and marketplace recommendations to address significant challenges in the US drug supply chain.
-
Press Release Eupraxia Pharmaceuticals Announces Filing of Preliminary Base Shelf Prospectus
Market news
FirstWordPharmaDecember 14, 2021
Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a clinical-stage biotechnology company with an innovative drug delivery platform technology, announced today that it has filed and obtained a receipt for a preliminary short form...
Pharma products for clinical purposes also require specialized packaging procedures compared to commercial products.
2020, the year of the COVID-19 pandemic, presented significant challenges to every market in the world. However, the pharmaceutical market has still been able to adapt to this new situation and continues to grow quickly.
There are many educational events in FDA throughout the year that focus on the pharmaceutical and regulatory industries.
There are thousands of drugs out there, each with specific benefits, potential side effects, and possible interactions, with many of the drugs being equivalent to one another or serving as alternative treatments for the same issue.
Medicine labeling is important and affects individual health on a daily basis, for patients, and the effectiveness of prescriptions for healthcare professionals.
As November approaches, the topic of the upcoming United States Presidential Election is becoming more and more significant.
Nonalcholic steatohepatitis (NASH) is a hard to diagnose liver disease, characterized by steatosis, chronic inflammation, and progressive fibrosis that may lead to cirrhosis, liver failure. NASH is also a significant risk factor for the development of hep
The Institute for In Vitro Sciences (IIVS) and Toxys have entered into a license agreement that allows IIVS to offer the ToxTracker assay.
American healthcare groups have released a series of policy and marketplace recommendations to address significant challenges in the US drug supply chain.
Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a clinical-stage biotechnology company with an innovative drug delivery platform technology, announced today that it has filed and obtained a receipt for a preliminary short form...
Pharma Sources Insight APRIL 2023
